SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Heart (CAMH)-What is this???
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Asymmetric who wrote (3)2/7/1997 9:50:00 AM
From: John Zwiener   of 33
 
Hi Peter, how do I get a copy of that transcript?

I have since found out more about this company and I believe it is very likely this will be a good one. This company is very similar to Igen International in it's small number of shares (12.4 million with a 2.5 million float), cookie cutter business, close to the green light to ramp up production, approved product with high potential due to neglected area (and cheaper in Igen's case)(CAMH has FDA approval, but will need labeling approval, so the current studies to be presented very soon do need to show the same thing as the pilot studies). I have made some recent comments about CAMH on the Igen International because of this precieved similarity.

I had been planning to repost here for the past week because I also noticed the increasing volume and felt with the small float that a price change was in the offing. It was a strange feeling to reread the info I had recieved on CAMH for the second time and to realize that there might be something here. Assuming the large studies come out well, and there is additional FDA approval, I think that this instrument will do well since it seems to have such a high rate of sorting out that percentage of patients who would be at risk of sudden cardiac death. A cardiologist would have to have one or lose patients (by death and by decreased referrals from other docs--the docs would send patients to cardiologists who could more completely work up the patient and give better treatment. (I do own this stock and i am an individual investor).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News